CEO & Co-Founder
Profile summary: MS in Business Engineering, Data Analytics at Universiteit Gent
AtlasXomics
AtlasXomics provides a spatial epigenome mapping solution at the single-cell level using the FlowGel220 kit, enabling precise analysis of gene regulation in oncology, neurology, and aging research. This technology addresses the need for high-resolution spatial context in epigenomic studies, facilitating a deeper understanding of cellular behavior and disease mechanisms.
- Data & Analytics
- Biotechnology
- Software Only
Updated 7 months ago
Funding
Raised to date
$16.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$700K across 1 disclosed round
$700K · Seed
Announced May 2024
Disclosed cumulative: $700K
Reported total $16.3M
Incomplete round history. $15.6M of the $16.3M reported total isn’t matched to a known round.
RoundDateAmountValuationInvestors
Founders
Product
Problem
Current methods for spatial epigenome mapping often lack single-cell resolution and can be cumbersome, hindering comprehensive analysis of gene regulation in complex tissues. Analyzing spatial data requires specialized bioinformatics expertise and high-performance computing infrastructure, creating a bottleneck for researchers.
Solution
AtlasXomics provides a comprehensive spatial epigenome mapping solution at single-cell resolution, enabling researchers to map gene regulation in oncology, neurology, and aging research. The FlowGel220 kit facilitates precise mapping of 5.5 mm x 5.5 mm regions at 10μm resolution. The company's technology combines microfluidics and Next Generation Sequencing (NGS) to create spatial tissue maps, revealing the mechanisms of disease. AtlasXomics also offers an intuitive cloud-based bioinformatics pipeline, allowing researchers to effortlessly analyze spatial data, map and compare clusters, annotate via marker genes, and visualize motif enrichments.
Target Audience
AtlasXomics targets researchers in oncology, neurology, and aging, as well as biotech companies seeking to understand disease mechanisms through spatial epigenomics.
Features
- FlowGel220 kit for high-performance spatial epigenome mapping at single-cell resolution
- Spatial ATAC-seq to map open chromatin regions
- Spatial CUT&Tag to map histone modifications and chromatin-associated proteins
- Intuitive bioinformatics pipeline for data analysis, including cluster mapping, marker gene annotation, and motif enrichment visualization
- Cloud-based platform for easy data exploration and analysis
- Capability to map gene by score and explore regulatory elements
- Service option to send samples for spatial epigenome analysis
- Inventor Kit for developing novel spatial omics solutions